Life Extension Magazine 2012
Epidemic of Immunosenescence
By Maegen Rawlls
Impressive results suggest that Reishi may, by restoring youthful immune strength and balance, add as many as 7 to 16 years to the human life span!
Immunosenescence refers to the gradual deterioration of the immune system brought on by normal aging.
This immune impairment involves the loss of our ability to combat infections and cancer, and to mount an antibody response even to vaccinations.
Immunosenescence is ubiquitous and a major contributory factor to increased disability and mortality among the elderly.1,2
While most doctors believe that immune decline is irreversible, traditional Chinese medicine has long used Reishi mushrooms to promote longevity and a vigorous immune system.
Now, remarkable scientific studies have found that the unique mix of compounds in this medicinal mushroom fights immuno-senescence and increases life span.3-5
The impressive results of a 2011 animal study suggest that Reishi may, by restoring youthful immune strength and balance, add as many as 7 to 16 years to the human life span!4
As we age, our immune system's protective function dramatically declines, reducing our ability to fight off disease and infection. This process—known as immunosenescence—also causes a marked acceleration of the aging process itself!
Immunosenescence is an insidious culprit that enables cancer, infection, and chronic inflammation to take possession of our maturing bodies.6-9
How Reishi Fights Immunosenescence
Reishi mushrooms attack and reverse immunosenescence through the combined effects of three compounds: first, a group of long-chain carbohydrates called polysaccharides, second, a unique protein named LZ-8 and third, a small group of steroid-like molecules called triterpenes.10-12
Together, these three Reishi components achieve the dual goals of promoting healthy immune responses against viral, bacterial, or fungal infections, while suppressing excessive or chronic inflammation that threatens long-term health.
Among its broad-spectrum immune-boosting effects are the following:
- Reishi promotes specialization of dendritic cells and macrophages. These cells are essential in allowing you to react to new threats, to vaccines, and, of course, to cancer cells.13-17
- Reishi's effects on dendritic cells have been proven to boost the response to tetanus vaccine. The mushroom's proteins are also under investigation as "adjuvants" to emerging cancer DNA vaccines and other immune-based cancer treatments.14,18-20
- Reishi polysaccharide triggers growth and development of bone marrow, where most immune cells are born. Following bone marrow eradication by chemotherapy, Reishi increased production of both red and white blood cells.21
- Reishi increases numbers and functions of virtually all cell lines in the immune system, such as natural killer cells, antibody-producing B cells, and the T cells responsible for rapid response to a new or "remembered" antigen.15,22,23
On the other side of the immunosenescence coin, Reishi's various components work to suppress inflammatory cytokines produced during chronic inflammation, as seen for example in rheumatoid arthritis, while maintaining normal acute inflammatory responses.16,24-27 Under conditions of chronic inflammation, Reishi reduces inflammatory promoters.28
Clinical studies support a role for Reishi in calming both asthma and allergic responses.29 In autoimmune diseases such as rheumatoid arthritis and Sjogren's Syndrome, Reishi extracts are showing promise in laboratory studies.30,31
Reishi Promotes Immune System's Anti-Cancer Surveillance
Reishi's multi-pronged modulation of the immune system has tremendous implications in prevention and treatment of cancer.32 That's because cancers typically develop ways to evade the immune system's defenses, while at the same time receiving stimulus and reinforcement from chronic inflammation.
Since Reishi boosts the immune system's ability to be on the lookout for cancer cells (this is called immunosurveillance by oncologists), while also reducing the inflammation that promotes cancers, the mushroom is a natural choice for defeating cancers before they gain traction.18,33-35 While large human studies have yet to be performed with Reishi, a stunning example of its potential effectiveness can be seen in the following case report.
A 47-year-old man was diagnosed with a large B-cell lymphoma in his stomach, following a biopsy in response to his complaint of abdominal pain.36 Eleven days later he underwent removal of his entire stomach, intended as a curative measure.
After the surgery when the pathologist examined the stomach, he found no evidence of the cancer. Instead, the cancer had been replaced by a dense layer of activated, healthy, normal T-lymphocytes — precisely the cells that, when activated, seek out and destroy cancer cells.
Only after this entirely unexpected finding did the doctors ask the man about supplements, and he then told them he'd taken large doses of Reishi for the five days following his diagnosis. The surgeons and pathologists hypothesized that the Reishi had stimulated the patient's T-cells, which had destroyed and replaced the cancer.36
A single case report, of course, is not a large, controlled clinical trial, but the dramatic outcome here is entirely consistent with the predicted effects of Reishi as an immune system stimulant.
Laboratory and animal studies confirm that Reishi stimulates an appropriate anticancer immune response while quashing a cancer-promoting inflammatory one, and a few small human studies demonstrate that Reishi enhances immune function in patients with advanced cancers.37-39
Reishi polysaccharides provide immune-boosting function to circulating cancer-killing white blood cells of various types.11 They also fight new blood vessel development required by solid tumors to support their rapid growth and expansion.11
Triterpenes from Reishi provide important anti-inflammatory effects that reduce the likelihood of a new cancer forming and that take away the inflammatory stimuli that promote early cancer development.28
These mechanisms, combined with their unique antioxidant characteristics, allow Reishi mushrooms to fight many different types of cancers, most notably those of the gastrointestinal tract (liver and colon), and reproductive system (breast and prostate).28,40-47 Reishi extracts have also proved useful in inducing cell death in various "white blood cell cancers" such as lymphoma, leukemia, and multiple myeloma cells.48
In each of these cancer types, Reishi mushroom extracts have been shown to prevent new tumors from arising, and in many cases to shrink existing tumors or pre-cancerous masses.49-52 These effects can be considered successful cancer prevention by immunosurveillance, because they may stop a tumor in its tracks before it ever reaches a detectable or dangerous size.49,50
Reishi Defends Against Infection
Reishi mushrooms' immune-stimulating effects play directly into their ability to fight off both bacterial and viral infections.53 Both polysaccharide and triterpene components of the mushrooms contribute to this activity.54,55
Reishi extracts have been shown to inhibit growth of a number of bacterial germs, especially infections of the urinary and digestive tracts.56 They also enhance the activity of standard antibiotics in treating bacterial infections. Scientists evaluated combinations of Reishi with four different antibiotics, and found an additive effect in most cases. And true synergy (the effect of both exceeds the combined effects of either alone) was demonstrated with the combination of Reishi and cefazolin, a common antibiotic for surgical infections.56
But it's in the realm of viral disease that Reishi mushrooms truly flex their muscles.57 In laboratory cell cultures, Reishi mushrooms stop or slow growth of influenza, HIV, hepatitis B, and many other viruses.57-59
Additional laboratory studies have shown that extracts from Reishi are especially effective against viruses in the herpes virus family, which include not only the well-known oral and genital herpes infections, but also the viruses that cause chickenpox and shingles, and the Epstein-Barr virus, a viral cause of certain lymphomas.54,60-62
In human studies, supplementation with Reishi dramatically shortens the time until symptomatic relief by more than 50% in people with oral or genital herpes, and in people with shingles, the excruciating adult sequel to childhood chickenpox infection.63,64
Reishi Mushrooms Extend Life Span
An international collaboration of researchers has led the way in studying the Reishi mushroom and its impact on aging. The group began their work by investigating properties of the Reishi mushroom and its most active compounds.3-5
What they found was that Reishi enhances cellular immune systems and promotes protective antibody production (boosting a healthy immune response), while also decreasing the body's load of inflammatory cytokines (suppressing a harmful immune response).4 In other words, Reishi fights immunosenescence and restores a healthy immune balance in older animals. It would be reasonable to predict that such an effect would combat most of the diseases that cause premature death, and thereby extend life.4
In fact, scientists have been interested in the longevity-promoting effect of Reishi for some time.4,5 To prove their theory, researchers initiated a 3-year study of Reishi extract in healthy middle-aged laboratory mice.4 The mice were randomly assigned to receive either regular mouse feed, or a feed mixed with one of several doses of Reishi mushroom extract.
After 88 weeks, a little more than halfway through the study, Reishi's powerful effects were already apparent. The Reishi-supplemented group proved to live much longer.8
As the study progressed, the longevity advantage became increasingly obvious. When 10% of the mice in each group were still alive, the supplemented mice went on to live another 148 days.4 In human terms, that's the equivalent of adding nearly 16 years of life span. Unlike some animal studies that use unrealistic doses for humans, this mouse study demonstrated extended life span and reduced risk of death using 175 mg/kg; that's equivalent to about 1,050 mg in an average 75 kg (165 pound) human.4
This study provided a dramatic demonstration of how fighting immunosenescence can promote remarkable gains in life span.
Other Benefits of Immune System Boosting By Reishi
There isn't room in a single article to go into the depth that Reishi's multiple additional characteristics warrant. Look forward in the future to learning more details about at least these three areas in which Reishi's reversal of immunosenescence plays a major role:
- Reishi is a promising candidate for management of allergic, asthmatic, and autoimmune disease symptoms, through its ability to suppress an inappropriately vigorous immune response.16,24,26,29-31,65-69
- Reishi promotes neuroprotection through a variety of mechanisms, including suppression of chronic inflammation and antioxidant functions.70-79
- Reishi extracts battle the epidemic of "diabesity," the conjoined effects of excessive body fat and elevated glucose; extracts lower blood sugar and limit excess fat storage while normalizing lipid profiles.80-89
Immunosenescence—the steady waning of your immune system's ability to fight disease without triggering excessive inflammation—markedly accelerates the aging process.
Loss of immune function through immunosenescence leaves us simultaneously vulnerable to infections and cancers, and also to the chronic inflammation that underlies other life-shortening illnesses.
The Reishi mushroom contains a trio of bioactive molecular families that fight immunosenescence, helping to restore both appropriate responses to infection and appropriate resolution of inflammation.
Reishi mushrooms can restore the vital immune balance you enjoyed in your youth, thus helping to slow aging processes. Should the results of animal studies on Reishi's impact on aging prove out in humans, we can expect life extensions of perhaps 7 to as many as 16 years.
Reishi deserves serious consideration as an immune balancing supplement with the potential of greater longevity.
If you have any questions on the scientific content of this article, please call a Life Extension® Health Advisor at 1-866-864-3027.
1. Muszkat ME. Greenbaum A. Ben-Yehuda M, et al. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine. Vaccine. 2003 21:(11–12);1180–6.
2. Ginaldi L, Loreto MF, Corsi MP, Modesti M, de MartinisM. Immunosenescence and infectious diseases. Microbes and Infection. 2001 3; (10):851–7.
3. Sanodiya BS, Thakur GS, Baghel RK, Prasad GB, Bisen PS. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol. 2009 Dec;10(8):717-42.
4. Wu Z, Zhang Y, Tan N, Zhao C, Yang J, Zhu J-S. ReishiMax extends the lifespan of mice: A preliminary report. The FASEB Journal. 2011 April;25(601.2).
5. Chuang MH, Chiou SH, Huang CH, Yang WB, Wong CH. The lifespan-promoting effect of acetic acid and Reishi polysaccharide. Bioorg Med Chem. 2009 Nov 15;17(22):7831-40.
6. Pfister G, Savino W. Can the immune system still be efficient in the elderly? An immunological and immunoendocrine therapeutic perspective. Neuroimmunomodulation. 2008;15(4-6):351-64.
7. Alonso-Fernandez P, De la Fuente M. Role of the immune system in aging and longevity. Curr Aging Sci. 2011 Jul;4(2):78-100.
8. Cannizzo ES, Clement CC, Sahu R, Follo C, Santambrogio L. Oxidative stress, inflammaging and immunosenescence. J Proteomics. 2011 Oct 19;74(11):2313-23.
9. Ostan R, Bucci L, Capri M, et al. Immunosenescence and immunogenetics of human longevity. Neuroimmunomodulation. 2008;15(4-6):224-40.
10. Bao X, Liu C, Fang J, Li X. Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum (Fr.) Karst. Carbohydr Res. 2001 May 8;332(1):67-74.
11. Xu Z, Chen X, Zhong Z, Chen L, Wang Y. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities. Am J Chin Med. 2011;39(1):15-27.
12. Yeh CH, Chen HC, Yang JJ, Chuang WI, Sheu F. Polysaccharides PS-G and protein LZ-8 from Reishi (Ganoderma lucidum) exhibit diverse functions in regulating murine macrophages and T lymphocytes. J Agric Food Chem. 2010 Aug 11;58(15):8535-44.
13. Cao LZ, Lin ZB. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol Lett. 2002 Oct 1;83(3):163-9.
14. Lai CY, Hung JT, Lin HH, et al. Immunomodulatory and adjuvant activities of a polysaccharide extract of Ganoderma lucidum in vivo and in vitro. Vaccine. 2010 Jul 12;28(31):4945-54.
15. Jan RH, Lin TY, Hsu YC, et al. Immuno-modulatory activity of Ganoderma lucidum-derived polysacharide on human monocytoid dendritic cells pulsed with Der p 1 allergen. BMC Immunol. 2011;12:31.
16. Ji Z, Tang Q, Zhang J, Yang Y, Liu Y, Pan YJ. Immunomodulation of bone marrow macrophages by GLIS, a proteoglycan fraction from Lingzhi or Reishi medicinal mushroom Ganoderma lucidium (W.Curt.:Fr.) P. Karst. Int J Med Mushrooms.2011;13(5):441-8.
17. Chan WK, Lam DT, Law HK, et al. Ganoderma lucidum mycelium and spore extracts as natural adjuvants for immunotherapy. J Altern Complement Med. 2005 Dec;11(6):1047-57.
18. Chu CL, Chen Dz C, Lin CC. A novel adjuvant Ling Zhi-8 for cancer DNA vaccines. Hum Vaccin. 2011 Nov;7(11):1161-4.
19. Lin CC, Yu YL, Shih CC, et al. A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells. Cancer Immunol Immunother. 2011 Jul;60(7): 1019-27.
20. Zhu XL, Liu JH, Li WD, Lin ZB. Promotion of myelopoiesis in myelosuppressed mice by Ganoderma lucidum polysaccharides. Front Pharmacol. 2012;3:20.
21. Zhu XL, Chen AF, Lin ZB. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J Ethnopharmacol. 2007 May 4;111(2):219-26.
22. Wang PY, Zhu XL, Lin ZB. Antitumor and immunomodulatory effects of polysaccharides from broken-spore of Ganoderma lucidum. Front Pharmacol. 2012;3:135.
23. Jeurink PV, Noguera CL, Savelkoul HF, Wichers HJ. Immunomodulatory capacity of fungal proteins on the cytokine production of human peripheral blood mononuclear cells. Int Immunopharmacol. 2008 Aug;8(8):1124-33.
24. Kohda H, Tokumoto W, Sakamoto K, et al. The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes. Chem Pharm Bull (Tokyo). 1985 Apr;33(4):1367- 74.
25. Ho YW, Yeung JS, Chiu PK, et al. Ganoderma lucidum polysaccharide peptide reduced the production of proinflammatory cytokines in activated rheumatoid synovial fibroblast. Mol Cell Biochem. 2007 Jul;301(1-2):173-9.
26. Ko HH, Hung CF, Wang JP, Lin CN. Antiinflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae. Phytochemistry. 2008 Jan;69(1):234-9.
27. Xi Bao Y, Kwok Wong C, Kwok Ming Li E, et al. Immunomodulatory effects of lingzhi and san-miao-san supplementation on patients with rheumatoid arthritis. Immunopharmacol Immunotoxicol. 2006;28(2):197-200.
28. Dudhgaonkar S, Thyagarajan A, Sliva D. Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum. Int Immunopharmacol. 2009 Oct;9(11):1272-80.
29. Mizutani N, Nabe T, Shimazu M, Yoshino S, Kohno S. Effect of Ganoderma lucidum on pollen-induced biphasic nasal blockage in a guinea pig model of allergic rhinitis. Phytother Res. 2012 Mar;26(3):325- 32.
30. Ho YW, Yeung JS, et al. Ganoderma lucidum polysaccharide peptide reduced the production of proinflammatory cytokines in activated rheumatoid synovial fibroblast. Mol Cell Biochem. 2007 Jul;301(1-2):173-9.
31. Qi G, Hua H, Gao Y, Lin Q, Yu GY. Effects of Ganoderma lucidum spores on sialoadenitis of nonobese diabetic mice. Chin Med J (Engl). 2009 Mar 5;122(5):556-60.
32. Zhang J, Tang Q, Zhou C, et al. GLIS, a bioactive proteoglycan fraction from Ganoderma lucidum, displays anti-tumour activity by increasing both humoral and cellular immune response. Life Sci. 2010 Nov 20;87(19-22):628-37.
33. Chen HS, Tsai YF, Lin S, et al. Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides. Bioorg Med Chem. 2004 Nov 1;12(21):5595-601.
34. Yue GG, Fung KP, Tse GM, Leung PC, Lau CB. Comparative studies of various ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro. J Altern Complement Med. 2006 Oct;12(8):777-89.
35. Pang X, Chen Z, Gao X, et al. Potential of a novel polysaccharide preparation (GLPP) from Anhui-grown Ganoderma lucidum in tumor treatment and immunostimulation. J Food Sci. 2007 Aug;72(6):S435-42.
36. Cheuk W, Chan JK, Nuovo G, Chan MK, Fok M. Regression of gastric large B-Cell lymphoma accompanied by a florid lymphoma-like T-cell reaction: immunomodulatory effect of Ganoderma lucidum (Lingzhi)? Int J Surg Pathol. 2007 Apr;15(2):180-6.
37. Wang SY, Hsu ML, Hsu HC, et al. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer. 1997 Mar 17;70(6):699-705.
38. Ooi VE, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem. 2000 Jul;7(7):715-29.
39. Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. 2003 Aug;32(3):201-15.
40. Lu H, Kyo E, Uesaka T, Katoh O, Watanabe H. A water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia suppresses azoxymethane-induction of colon cancers in male F344 rats. Oncol Rep. 2003 Mar-Apr;10(2):375-9.
41. Chen NH, Liu JW, Zhong JJ. Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression. Pharmacol Rep. 2010 Jan-Feb;62(1):150-63.
42. Jang KJ, Son IS, Shin DY, Yoon HM, Choi YH. Anti-invasive activity of ethanol extracts of Ganoderma lucidum through tightening of tight junctions and inhibition of matrix metalloproteinase activities in human gastric carcinoma cells. J Acupunct Meridian Stud. 2011 Dec;4(4):225-35.
43. Shang D, Li Y, Wang C, Wang X, Yu Z, Fu X. A novel polysaccharide from Se-enriched Ganoderma lucidum induces apoptosis of human breast cancer cells. Oncol Rep. 2011 Jan;25(1):267-72.
44. Lu H, Song J, Jia XB, Feng L. Antihepatoma activity of the acid and neutral components from Ganoderma lucidum. Phytother Res. 2012 Jan 25.
45. Wu GS, Lu JJ, Guo JJ, et al. Ganoderic acid DM, a natural triterpenoid, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Fitoterapia. 2012 Mar;83(2):408-14.
46. Liu J, Shimizu K, Konishi F, Kumamoto S, Kondo R. The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum. Bioorg Med Chem. 2007 Jul 15;15(14): 4966-72.
47. Zaidman BZ, Wasser SP, Nevo E, Mahajna J. Androgen receptor- dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells. Int J Oncol. 2007 Oct;31(4):959-67.
48. Muller CI, Kumagai T, O'Kelly J, Seeram NP, Heber D, Koeffler HP. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk Res. 2006 Jul;30(7):841-8.
49. Lu H, Uesaka T, Katoh O, Kyo E, Watanabe H. Prevention of the development of preneoplastic lesions, aberrant crypt foci, by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male F344 rats. Oncol Rep. 2001 Nov-Dec;8(6):1341-5.
50. Lu H, Kyo E, Uesaka T, Katoh O, Watanabe H. Prevention of development of N,N'-dimethylhydrazine-induced colon tumors by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male ICR mice. Int J Mol Med. 2002 Feb;9(2):113-7.
51. Oka S, Tanaka S, Yoshida S, et al. A water-soluble extract from culture medium of Ganoderma lucidum mycelia suppresses the development of colorectal adenomas. Hiroshima J Med Sci. 2010 Mar;59(1):1-6.
52. Joseph S, Sabulal B, George V, Antony KR, Janardhanan KK. Antitumor and anti-inflammatory activities of polysaccharides isolated from Ganoderma lucidum. Acta Pharm. 2011 Sep 1;61(3):335-42.
53. Karaman M, Jovin E, Malbasa R, Matavuly M, Popovic M. Medicinal and edible lignicolous fungi as natural sources of antioxidative and antibacterial agents. Phytother Res. 2010 Oct;24(10):1473-81.
54. Iwatsuki K, Akihisa T, Tokuda H, et al. Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation. J Nat Prod. 2003 Dec;66(12):1582-5.
55. Li Z, Liu J, Zhao Y. Possible mechanism underlying the antiherpetic activity of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro. J Biochem Mol Biol. 2005 Jan 31;38(1):34-40.
56. Yoon SY, Eo SK, Kim YS, Lee CK, Han SS. Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch Pharm Res. 1994 Dec;17(6):438-42.
57. Eo SK, Kim YS, Lee CK, Han SS. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. J Ethnopharmacol. 1999 Dec 15;68(1-3):129-36.
58. Li YQ, Wang SF. Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum. Biotechnol Lett. 2006 Jun;28(11):837-41.
59. el-Mekkawy S, Meselhy MR, Nakamura N, et al. Anti-HIV-1 and anti- HIV-1-protease substances from Ganoderma lucidum. Phytochemistry. 1998 Nov;49(6):1651-7.
60. Eo SK, Kim YS, Lee CK, Han SS. Antiherpetic activities of various protein bound polysaccharides isolated from Ganoderma lucidum. J Ethnopharmacol. 1999 Dec 15;68(1-3):175-81.
61. Eo SK, Kim YS, Lee CK, Han SS. Possible mode of antiviral activity of acidic protein bound polysaccharide isolated from Ganoderma lucidum on herpes simplex viruses. J Ethnopharmacol. 2000 Oct;72(3):475-81.
62. Oh KW, Lee CK, Kim YS, Eo SK, Han SS. Antiherpetic activities of acidic protein bound polysacchride isolated from Ganoderma lucidum alone and in combinations with acyclovir and vidarabine. J Ethnopharmacol. 2000 Sep;72(1-2):221-7.
63. Hijikata Y, Yasuhara A, Sahashi Y. Effect of an herbal formula containing Ganoderma lucidum on reduction of herpes zoster pain: a pilot clinical trial. Am J Chin Med. 2005;33(4):517-23.
64. Hijikata Y, Yamada S, Yasuhara A. Herbal mixtures containing the mushroom Ganoderma lucidum improve recovery time in patients with herpes genitalis and labialis. J Altern Complement Med. 2007 Nov;13(9):985-7.
65. Tasaka K, Akagi M, Miyoshi K, Mio M, Makino T. Anti-allergic constituents in the culture medium of Ganoderma lucidum. (I). Inhibitory effect of oleic acid on histamine release. Agents Actions. 1988 Apr;23(3- 4):153-6.
66. Tasaka K, Mio M, Izushi K, Akagi M, Makino T. Anti-allergic constituents in the culture medium of Ganoderma lucidum. (II). The inhibitory effect of cyclooctasulfur on histamine release. Agents Actions. 1988 Apr;23(3-4):157-60.
67. Andoh T, Zhang Q, Yamamoto T, et al. Inhibitory effects of the methanol extract of Ganoderma lucidum on mosquito allergy-induced itch-associated responses in mice. J Pharmacol Sci. 2010;114(3):292-7.
68. Zhang Q, Andoh T, Konno M, Lee JB, Hattori M, Kuraishi Y. Inhibitory effect of methanol extract of Ganoderma lucidum on acute itch-associated responses in mice. Biol Pharm Bull. 2010;33(5):909-11.
69. Liu YH, Tsai CF, Kao MC, Lai YL, Tsai JJ. Effectiveness of Dp2 nasal therapy for Dp2-induced airway inflammation in mice: using oral Ganoderma lucidum as an immunomodulator. J Microbiol Immunol Infect. 2003 Dec;36(4):236-42.
70. Chen LW, Horng LY, Wu CL, Sung HC, Wu RT. Activating mitochondrial regulator PGC-1alpha expression by astrocytic NGF is a therapeutic strategy for Huntington's disease. Neuropharmacology. 2012 May 24.
71. Cheung WM, Hui WS, Chu PW, Chiu SW, Ip NY. Ganoderma extract activates MAP kinases and induces the neuronal differentiation of rat pheochromocytoma PC12 cells. FEBS Lett. 2000 Dec 15;486(3):291-6.
72. Ding H, Zhou M, Zhang RP, Xu SL. Ganoderma lucidum extract protects dopaminergic neurons through inhibiting the production of inflammatory mediators by activated microglia. Sheng Li Xue Bao. 2010 Dec 25;62(6):547-54.
73. Lai CS, Yu MS, Yuen WH, So KF, Zee SY, Chang RC. Antagonizing beta-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum. Brain Res. 2008 Jan 23;1190:215-24.
74. Lee I, Ahn B, Choi J, Hattori M, Min B, Bae K. Selective cholinesterase inhibition by lanostane triterpenes from fruiting bodies of Ganoderma lucidum. Bioorg Med Chem Lett. 2011 Nov 1;21(21):6603-7.
75. Patocka J. Anti-inflammatory triterpenoids from mysterious mushroom Ganoderma lucidum and their potential possibility in modern medicine. Acta Medica (Hradec Kralove). 1999;42(4):123-5.
76. Zhang R, Xu S, Cai Y, Zhou M, Zuo X, Chan P. Ganoderma lucidum protects dopaminergic neuron degeneration through inhibition of microglial activation. Evid Based Complement Alternat Med. 2011;2011:156810.
77. Zhao HB, Lin SQ, Liu JH, Lin ZB. Polysaccharide extract isolated from ganoderma lucidum protects rat cerebral cortical neurons from hypoxia/reoxygenation injury. J Pharmacol Sci. 2004 Jun;95(2):294-8.
78. Zhou Y, Qu ZQ, Zeng YS, et al. Neuroprotective effect of preadministration with Ganoderma lucidum spore on rat hippocampus. Exp Toxicol Pathol. 2011 Jan 15.
79. Zhou ZY, Tang YP, Xiang J, et al. Neuroprotective effects of water- soluble Ganoderma lucidum polysaccharides on cerebral ischemic injury in rats. J Ethnopharmacol. 2010 Aug 19;131(1):154-64.
80. Wang CD, Teng BS, He YM, et al. Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice. Br J Nutr. 2012 Mar 27:1-12.
81. Zhang HN, He JH, Yuan L, Lin ZB. In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage. Life Sci. 2003 Sep 19;73(18):2307-19.
82. Xue H, Qiao J, Meng G, et al. Effect of Ganoderma lucidum polysaccharides on hemodynamic and antioxidation in T2DM rats. Zhongguo Zhong Yao Za Zhi. 2010 Feb;35(3):339-43.
83. Yang Q, Wang S, Xie Y, Sun J, Wang J. HPLC analysis of Ganoderma lucidum polysaccharides and its effect on antioxidant enzymes activity and Bax, Bcl-2 expression. Int J Biol Macromol. 2010 Mar 1;46(2):167-72.
84. Thyagarajan-Sahu A, Lane B, Sliva D. ReishiMax, mushroom based dietary supplement, inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK. BMC Complement Altern Med. 2011;11:74.
85. Seto SW, Lam TY, Tam HL, et al. Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice. Phytomedicine. 2009 May;16(5):426-36.
86. Kino K, Mizumoto K, Sone T, et al. An immunomodulating protein, Ling Zhi-8 (LZ-8) prevents insulitis in non-obese diabetic mice. Diabetologia. 1990 Dec;33(12):713-8.
87. Li F, Zhang Y, Zhong Z. Antihyperglycemic effect of Ganoderma lucidum polysaccharides on streptozotocin-induced diabetic mice. Int J Mol Sci. 2011;12(9):6135-45.
88. Teng BS, Wang CD, Yang HJ, et al. A protein tyrosine phosphatase 1B activity inhibitor from the fruiting bodies of Ganoderma lucidum (Fr.) Karst and its hypoglycemic potency on streptozotocin-induced type 2 diabetic mice. J Agric Food Chem. 2011 Jun 22;59(12):6492-500.
89. Teng BS, Wang CD, Zhang D, et al. Hypoglycemic effect and mechanism of a proteoglycan from Ganoderma lucidum on streptozotocin-induced type 2 diabetic rats. Eur Rev Med Pharmacol Sci. 2012 Feb;16(2):166-75.
90. Pinti M, Nasi M, Lugli E, et al. T cell homeostasis in centenarians: from the thymus to the periphery. Curr Pharm Des. 2010;16(6):597-603.
91. Sansoni P, Vescovini R, Fagnoni F, et al. The immune system in extreme longevity. Exp Gerontol. 2008 Feb;43(2):61-5.
92. Weaver BA. Herpes zoster overview: natural history and incidence. J Am Osteopath Assoc. 2009 Jun;109(6 Suppl 2):S2-6.
93. Ponnappan S, Ponnappan U. Aging and immune function: molecular mechanisms to interventions. Antioxid Redox Signal. 2011 Apr 15;14(8):1551-85.
94. Fulop T, Larbi A, Kotb R, de Angelis F, Pawelec G. Aging, immunity, and cancer. Discov Med. 2011 Jun;11(61):537-50.
95. Cao W, Kim JH, Chirkova T, et al. Improving immunogenicity and effectiveness of influenza vaccine in older adults. Expert Rev Vaccines. 2011 Nov;10(11):1529-37.
96. Levin MJ. Immune senescence and vaccines to prevent herpes zoster in older persons. Curr Opin Immunol. 2012 Aug;24(4):494-500.
97. Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol. 2010 May;48 Suppl 1:S2-7.
98. Fletcher AL, Calder A, Hince MN, Boyd RL, Chidgey AP. The contribution of thymic stromal abnormalities to autoimmune disease. Crit Rev Immunol. 2011;31(3):171-87.
99. Provinciali M, Cardelli M, Marchegiani F. Inflammation, chronic obstructive pulmonary disease and aging. Curr Opin Pulm Med. 2011 Dec;17 Suppl 1:S3-10.
100. Larbi A, Franceschi C, Mazzatti D, Solana R, Wikby A, Pawelec G. Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda). 2008 Apr;23:64-74.
101. Chinn IK, Blackburn CC, Manley NR, Sempowski GD. Changes in primary lymphoid organs with aging. Semin Immunol. 2012 May 2.
102. Maiese K, Chong ZZ, Shang YC. OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins. Trends Mol Med. 2008 May;14(5):219-27.
103. Maiese K, Hou J, Chong ZZ, Shang YC. A fork in the path: Developing therapeutic inroads with FoxO proteins. Oxid Med Cell Longev. 2009 Jul-Aug;2(3):119-29.
104. Hoogeboom D, Burgering BM. Should I stay or should I go: beta-catenin decides under stress. Biochim Biophys Acta. 2009 Dec;1796(2):63-74.
105. Maiese K, Chong ZZ, Shang YC. "Sly as a FOXO": new paths with Forkhead signaling in the brain. Curr Neurovasc Res. 2007 Nov;4(4):295-302.